Articles on Breast Cancer
What is the BRCA gene test?
- Every woman with a BRCA mutation is at high risk for breast cancer, irrespective of whether she has a family history of breast cancer or not.
- By age 80, a woman with a BRCA mutation has about an 80% chance of developing breast cancer.
- BRCA1 and BRCA2 gene mutations also increase the risk of ovarian cancer, by 54% and 23%, respectively.
- Inherited BRCA1 or BRCA2 mutations account for 5-10% of all breast cancers.
What are the purposes of breast cancer BRCA gene test?
- The BRCA gene test analyses DNA to look for harmful mutations in two breast cancer genes (BRCA1 or BRCA2).
- Medical professionals perform this test as a routine blood test.
- The test should only be performed on patients who have specific types of breast cancers or have a family history suggesting the possibility of having an inherited mutation.
- These mutations are uncommon, and inherited BRCA gene mutations are responsible for about 5%-10% of breast cancers.
Who is a candidate for BRCA gene testing?
Discuss this with your health care provider or treatment team as this information is frequently updated. Guidelines for testing may include the following:
- A personal history of breast cancer diagnosis at a young age, bilateral breast cancer, breast and ovarian cancer diagnosis, or a personal history of ovarian cancer
- A personal history of bilateral breast cancer (cancer in both breasts)
- A personal history of triple negative breast cancer (breast cancer that is estrogen receptor-negative, progesterone receptor-negative and HER2-negative) diagnosed at age 60 or younger
- Ashkenazi Jewish heritage and a personal history of breast cancer
- A family history of breast cancer at a young age (under 50) or ovarian cancer and a personal history of breast cancer
- A person or a family member with bilateral breast cancer, ovarian cancer, or both breast and ovarian cancer
- A relative with a known BRCA1 or BRCA2 mutation
- A personal or family history of male breast cancer
There is only a very small chance your family carries a BRCA1/2 mutation if you or a family member is the only person in your family with breast cancer and breast cancer occurred at an older age.
In most cases, genetic testing is not recommended when there is a low chance of finding a mutation.
Most breast cancers are not due to a BRCA1/2 or other inherited gene mutation linked to breast cancer
What are the risks and benefits of BRCA gene test?
A health care provider or genetic counselor can talk with you about the risks, benefits, and issues you may face when you are considering genetic testing.
Testing for BRCA1 and BRCA2 gene mutations requires a blood or saliva sample.
There can be physical, emotional and financial impacts of knowing your genetic status. That's why testing for a BRCA1/2 mutation is only recommended for people who fall into one of the above guidelines.
Even if it’s recommended, genetic testing is a personal decision. A genetic counselor can help you decide if BRCA1/2 testing is right for you.
Testing for BRCA 1/2 mutations
In most cases, the person with cancer is tested first.
- If no BRCA1/2 mutation is found, the cancer was not due to a BRCA1 or BRCA2 mutation.
- If a BRCA1/2 mutation is found, other family members can be tested for the specific mutation.
Just because one person in the family has a mutation doesn’t mean everyone in the family has the mutation. Only identical twins have the exact same genes. Other family members share some, but not all, of their genes.
For example, if your mother has a BRCA1 mutation, there's a 50 percent chance you will have a BRCA1 mutation (you get half of your genes from your mother and a half from your father).
If your family members with breast cancer or ovarian cancer are deceased or aren't willing to be tested (or if your family medical history is unknown), a genetic counselor can help you decide whether it would be useful to have BRCA1/2 testing.
Latest Cancer News
Health Solutions From Our Sponsors
Salerno, K.E. "NCCN Guidelines Update: Evolving Radiation Therapy Recommendations for Breast Cancer." J Natl Compr Canc Netw 15(5S) May 2017: 682-684.
Shield, Kevin D., et al. "Alcohol Use and Breast Cancer: A Critical Review." Alcoholism: Clinical and Experimental Research Apr. 30, 2016.
Top Breast Cancer/BRCA gene test Related Articles
Breast Cancer Facts
Breast cancer is the most common non-skin cancer of American women, but it can also occur in men. Every year in the U.S., there are over 266,000 new diagnoses of breast cancer. A woman has a risk of one in eight for developing breast cancer at some point during her lifetime.
Can Fibroadenomas Turn Into Breast Cancer?A fibroadenoma is the most common type of benign, non-cancerous lump of the breast. Although it is rare, complex fibroadenomas and phyllodes tumors have a chance to develop into malignant breast cancer.
Cyramza (ramucirumab)Cyramza (ramucirumab) is a prescription medication used for cancer treatment, which is given through intravenous (IV) infusion. Cyramza is a human vascular endothelial growth factor receptor 2 antagonist that specifically binds VEGF Receptor 2 and blocks binding of VEGFR ligands, VEGF-A, VEGF-C, and VEGF-D. As a result, ramucirumab inhibits ligand-stimulated activation of VEGF Receptor 2, thereby inhibiting ligand-induced proliferation, and migration of human endothelial cells. Cyramza is used to treat the following types of cancer: Advanced or Metastatic Stomach or Gastroesophageal (GE) Junction Cancer, Metastatic Non-Small Cell Lung Cancer (NSCLC), Metastatic Colorectal Cancer (CRC), and AFP-High Liver Cancer (Hepatocellular Carcinoma). Serious side effects of Cyramza include hemorrhage, gastrointestinal perforation, impaired wound healing, and more. The safety and effectiveness of Cyramza in pediatric patients have not been established. Cyramza can cause fetal harm and impair fertility. It is not known if Cyramza is secreted in breast milk.
How Can You Detect Breast Cancer Early?Breast cancer develops from the cells of the breasts and can spread to other parts of the body (metastasis). It is one of the most common cancers diagnosed in women in the United States. A lump in the breast or armpit is often the first sign. Treatment success depends largely on early detection.
How Long Does Tracheal Resection Take?Tracheal resection is a surgical procedure of the windpipe. The procedure involves removing a part of the windpipe and stitching back the remaining part. Tracheal resection is most commonly performed in cases of cancers involving the windpipe or secondary to injury or sometimes after an incision in the windpipe made to relieve an obstruction to breathing (tracheostomy). Tracheal resection is performed when there is significant narrowing in the windpipe.
Kisqali (ribociclib)Kisqali (ribociclib) is a prescription medicine used in combination with an aromatase inhibitor to treat pre/perimenopausal or postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that has spread to other parts of the body (metastatic), as the first endocrine based therapy; or fulvestrant to treat postmenopausal women with HR-positive, HER2-negative metastatic breast cancer as the first endocrine based therapy or with disease progression following endocrine therapy. The most common side effects of Kisqali include neutropenia, diarrhea, headache, nausea, leukopenia, constipation, infections, vomiting, rash, fatigue, hair loss, and cough. Serious side effects of Kisqali include lung problems, heart rhythm problems, liver problems, and low white blood cell counts.
Verzenio (abemaciclib)Verzenio (abemaciclib) is a an oral tablet that attacks tumor cells in patients with HR+/HER2- breast cancer. Verzenio attacks proteins that govern how quickly cancer cells need to grow and reproduce, making it difficult for the cancer cells to continue growing. Common side effects include diarrhea, low white blood cell count, interstitial lung disease, and liver toxicity.
What Are the Four Types of Breast Cancer?The four most common types of breast cancer are ductal carcinoma in situ, lobular carcinoma in situ, invasive ductal carcinoma, invasive lobular carcinoma. The designations are based on the locations of the tumors, whether they have spread and where they have spread to.
What Is Usually the First Sign of Breast Cancer?A lump in the breast or in the armpits is often the first sign of breast cancer. This may be felt while in the shower. There may or may not be changes in the structure of the breast. Other early signs include changes in breast skin, breast pain and others.